Haemophilia
📧 Sign up to get email alerts when something new happens for Haemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery [Phase 3]
Phase 3 open-study assessing safety and efficacy of Replenine-VF in haemophilia B patients undergoing surgery has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery. [Phase 3]
Phase 3 trial update for Replenine-VF in haemophilia B patients undergoing major surgery; study completed.
-
CLINICAL_TRIALS trial_result · 2018-02-22Clinical Trial Update: An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients [Phase 3]
Phase 3 trial investigating safety and efficacy of Replenine-VF in severe Haemophilia B has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients. [Phase 3]
A Phase 3 open study assessing the safety and efficacy of Optivate in patients with severe Haemophilia A has completed.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A. [Phase 3]
Phase 3 trial update assessing safety and efficacy of Optivate® in children under 6 with Haemophilia A has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-02-15Clinical Trial Update: An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery. [Phase 3]
Phase 3 open study assessing safety and efficacy of Optivate in haemophilia A patients undergoing surgery has completed.
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Assess the Safety and Efficacy of Individually Tailored Prophylaxis With Human-cl rhFVIII in Patients With Severe Haemophilia A [Phase 3]
Phase 3 trial assessing safety and efficacy of individually tailored prophylaxis with human-cl rhFVIII for severe haemophilia A has complete…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. [Phase 3]
A Phase 3 trial evaluating the safety, efficacy and pharmacokinetics of NNC-0156-0000-0009 in previously treated children with Haemophilia B…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Combining Registry Data in Haemophilia: TARGET H
A completed registry-based study in haemophilia under the TARGET H program, evaluating methods to combine registry data.
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015 [Phase 3]
Extension results from Phase 3 trials evaluating safety and efficacy of Turoctocog alfa (N8) for prophylaxis and on-demand treatment of blee…
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of NNC-0156-0000-0009 during surgical procedures in people with Haemophilia B has …
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Trial Investigating Safety, Pharmacokinetics and Pharmacodynamics of Concizumab Administered Subcutaneously to Haemophilia A Subjects [Phase 1]
This Phase 1 trial update reports on the safety, pharmacokinetics and pharmacodynamics of subcutaneously administered concizumab in haemophi…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects [Phase 1]
Phase 1 pharmacokinetic study of NNC172-2021 at two dose levels in healthy Japanese subjects; trial status completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Survey Evaluating the Psychosocial Effects of Living With Haemophilia
A completed clinical trial update describing a survey evaluating the psychosocial effects of living with haemophilia and related congenital …
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A [Phase 1]
Phase 1 clinical trial evaluating the safety and pharmacokinetics of NNC 0129-0000-1003 in subjects with Haemophilia A has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects [Phase 1]
Phase 1 clinical trial evaluating pharmacokinetics and safety of N8 versus Advate in Haemophilia A subjects.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543 [Phase 1]
Phase 1 extension results from a single-dose trial of the recombinant Factor VIII (N8) in Japanese subjects with Haemophilia A.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B [Phase 1]
Phase 1 safety study of a 40 kDa pegylated recombinant factor IX in non-bleeding patients with Haemophilia B has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries
This completed epidemiological study sponsored by Novo Nordisk evaluates haemophilia care and orthopedic status in developing countries.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State [Phase 1]
This Phase 1 pharmacokinetic study evaluated a single bolus dose of NovoSeven in paediatric and adult patients with Haemophilia A or Haemoph…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors [Phase 4]
Phase 4 trial update evaluating high-dose activated recombinant human factor VII to treat mild to moderate joint bleeds in haemophilia patie…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX
This completed observational diary study collected data on treatment-dose patterns among patients with haemophilia A or B with inhibitors to…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients [Phase 1]
Phase 1 trial evaluating safety and pharmacokinetics of two single doses of NNC128-0000-2011 in haemophilia A or haemophilia B patients; the…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B [Phase 1]
Phase 1 study evaluating safety and mode of action of a long-acting activated recombinant human factor VII in patients with haemophilia A or…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Project to Update the Study of Congenital Haemophilia in Spain
This document reports a completed clinical trial update in Spain for congenital haemophilia, involving Haemophilia A and Haemophilia B. The …